Longitudinal Measurement Invariance of the Metabolic Syndrome: Is the Assessment of the Metabolic Syndrome Stable Over Time?

Annals of Epidemiology

Volumn 21, Issue 2, 2011, Pages 111-117

  Barbosa Leiker, Celestina ^a,b   Wright, Bruce R ^a   Burns, G Leonard ^a   Parks, Craig D ^a   Strand, Paul S ^c  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Factor Analysis; Metabolic Syndrome X

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CLINICAL ASSESSMENT; CONCEPTUAL FRAMEWORK; DIASTOLIC BLOOD PRESSURE; FACTORIAL ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; HUMANS; LIPOPROTEINS, LDL; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; TRIGLYCERIDES;

EID: 78650352258     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2010.10.001     Document Type: Article

References (40)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult treatment panel III). JAMA 2001, 285:2486-2497.
2. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
3. Liese A.D., Mayer-Davis E.J., Haffner S.M. Development of the multiple metabolic syndrome: An epidemiologic perspective. Epidemiol Rev 1998, 20:157-172.
4. Meigs J.B. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000, 152:908-911. discussion 912.
5. Li C., Ford E.S. Is there a single underlying factor for the metabolic syndrome in adolescents? A confirmatory factor analysis. Diabetes Care 2007, 30:1556-1561.
6. Novak S., Stapleton L.M., Litaker J.R., Lawson K.A. A confirmatory factor analysis evaluation of the coronary heart disease risk factors of metabolic syndrome with emphasis on the insulin resistance factor. Diabetes Obes Metab 2003, 5:388-396.
7. Pladevall M., Singal B., Williams L.K., Bro- tons C., Guyer H., Sadurni J., et al. A single factor underlies the metabolic syndrome: A confirmatory factor analysis. Diabetes Care 2006, 29:113-122.
8. Shah S., Novak S., Stapleton L.M. Evaluation and comparison of models of metabolic syndrome using confirmatory factor analysis. Eur J Epidemiol 2006, 21:343-349.
9. Shen B.J., Todaro J.F., Niaura R., McCaffery J.M., Zhang J., Spiro A., et al. Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am J Epidemiol 2003, 157:701-711.
10. Shen B.J., Goldberg R.B., Llabre M.M., Schneiderman N. Is the factor structure of the metabolic syndrome comparable between men and women and across three ethnic groups: the Miami Community Health Study. Ann Epidemiol 2006, 16:131-137.
11. Lempiainen P., Mykkanen L., Pyorala K., Laakso M., Kuusisto J. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 1999, 100:123-128.
12. Pyorala M., Miettinen H., Halonen P., Laakso M., Pyorala K. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: The 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 2000, 20:538-544.
13. Lindblad U., Langer R.D., Wingard D.L., Thomas R.G., Barrett-Connor E.L. Metabolic syndrome and ischemic heart disease in elderly men and women. Am J Epidemiol 2001, 153:481-489.
14. Hanson R.L., Imperatore G., Bennett P.H., Knowler W.C. Components of the " metabolic syndrome" and incidence of type 2 diabetes. Diabetes 2002, 51:3120-3127.
15. Hanley A.J., Festa A., D'Agostino R.B., Wagenknecht L.E., Savage P.J., Tracy R.P., et al. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: Factor analysis using directly measured insulin sensitivity. Diabetes 2004, 53:1773-1781.
16. Wang J.J., Qiao Q., Miettinen M.E., Lappalainen J., Hu G., Tuomilehto J. The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a chinese population with high postprandial glucose. Diabetes Care 2004, 27:2429-2437.
17. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-2716.
18. Ferguson T.F., Funkhouser E., Roseman J. Factor analysis of metabolic syndrome components in the Coronary Artery Risk Development in Young Adults (CARDIA) study: Examination of factors by race-sex groups and across time. Ann Epidemiol 2010, 20:194-200.
19. Cheung G.W., Rensvold R.B. Evaluating goodness-of-fit indexes for testing measurement invariance. Structural Equation Modeling 2002, 9:233-255.
20. Vandenberg R.J., Lance C.E. A review and synthesis of the measurement invariance literature: Suggestions, practices, and recommendations for organizational research. Org Res Methods 2000, 3:4-69.
21. Brown T.A. Confirmatory Factor Analysis for Applied Research 2006, Guilford Press, New York.
22. Steenkamp J.-B.E.M., Baumgartner H. Assessing measurement invariance in cross-national consumer research. J Consumer Res 1998, 25:78-90.
23. Chen F.F., Sousa K.H., West S.G. Testing measurement invariance of second-order factor models. Structural Equation Modeling 2005, 12:471-492.
24. Tuttle K.R., Short R. Longitudinal relationships among coronary artery calcification, serum phosphorus, and kidney function. Clin J Am Soc Nephrol 2009, 4:1968-1973.
25. Mielke C.H., Shields J.P., Broemeling L.D. Coronary artery calcium scores for men and women in a large asymptomatic population. Cardiovasc Disease Prev 1999, 2:194-198.
26. Pickering T.G., Hall J.E., Appel L.J., Falkner B.E., Graves J., Hill M.N., et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: Blood pressure measurement in humans: A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005, 45:142-161.
27. World Health Organization Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complication: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus 1999, World Health Organization, Geneva, Switzerland.
28. American Heart Association. Control your risk factors for high blood pressure. Available at: Accessed August 5, 2009. http://www.americanheart.org/presenter.jhtml?identifier=581.
29. Horn J.L., McArdle J.J. A practical and theoretical guide to measurement invariance in aging. Exp Aging Res 1992, 18:117-144.
30. Meredith W. Measurement invariance, factor analysis and factorial invariance. Psychometrika 1993, 58:525-543.
31. Chen F.F. Sensitivity of goodness of fit indexes to lack of measurement invariance. Structural Equation Modeling 2007, 14:464-504.
32. Meade A.W., Johnson E.C., Braddy P.W. Power and sensitivity of alternative fit indices in tests of measurement invariance. J Appl Psychol 2008, 93:568-592.
33. Muthén L., Muthén B.O. Mplus Users' Guide 1998-2007, Muthén, Los Angeles.
34. Muthén L, Muthén BO. Mplus Technical Appendices. Available at: Accessed September 2, 2010. http://www.statmodel.com/chidiff.shtml.
35. Mannucci E., Monami M., Rotella C.M. How many components for the metabolic syndrome? Results of exploratory factor analysis in the FIBAR study. Nutr Metab Cardiovasc Dis 2007, 17:719-726.
36. Ingram D.G. Is the metabolic syndrome a discrete diagnostic category or the end of a continuum? Taxometric evidence for dimensionality in the National Health and Nutrition Examination Survey 1999-2004. Ann Epidemiol 2009, 19:143-147.
37. Meredith W., Horn J. The role of factorial invariance in modeling growth and change. New Methods for the Analysis of Change (Decade of Behavior) 2001, 203-240. American Psychological Association, Washington, DC. L.M. Collins, A. Sayer (Eds.).
38. Bontempo D.E., Hofer S.M. Assessing factorial invariance in cross-sectional and longitudinal studies. Oxford Handbook of Methods in Positive Psychology 2007, 153-175. Oxford University Press, New York. A.D. Ong, M.H.M. van Dulmen (Eds.).
39. Yudkin J.S. Insulin resistance and the metabolic syndrome-or the pitfalls of epidemiology. Diabetologia 2007, 50:1576-1586.
40. Ventura A.K., Loken E., Birch L.L. Risk profiles for metabolic syndrome in a nonclinical sample of adolescent girls. Pediatrics 2006, 118:2434-2442.